SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

ETR:1SXP Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	2,569	3,178	4,618	4,765	-	-
Market Cap Growth	-34.76%	-31.18%	-3.10%	-	-	-
Enterprise Value	2,845	3,440	4,867	4,914	-	-
Last Close Price	17.06	20.84	30.07	30.91	-	-
PE Ratio	17.95	21.70	30.85	31.38	-	-
Forward PE	16.88	19.36	30.23	-	-	-
PS Ratio	2.59	3.22	4.83	5.30	-	-
PB Ratio	2.72	3.56	5.86	6.89	-	-
P/TBV Ratio	2.82	3.69	6.11	7.23	-	-
P/FCF Ratio	43.52	89.28	57.95	770.48	-	-
P/OCF Ratio	12.69	17.66	20.55	26.23	-	-
PEG Ratio	2.25	1.71	2.66	-	-	-
EV/Sales Ratio	2.87	3.49	5.09	5.47	-	-
EV/EBITDA Ratio	10.28	13.25	19.55	22.59	-	-
EV/EBIT Ratio	14.85	18.52	25.77	28.70	-	-
EV/FCF Ratio	48.19	96.63	61.07	794.52	-	-
Debt / Equity Ratio	0.32	0.34	0.36	0.30	0.28	0.24
Debt / EBITDA Ratio	1.15	1.14	1.13	0.94	0.92	0.67
Debt / FCF Ratio	5.11	8.51	3.59	33.92	6.49	2.95
Net Debt / Equity Ratio	0.29	0.31	0.33	0.27	0.23	0.17
Net Debt / EBITDA Ratio	1.07	1.07	1.04	0.85	0.78	0.48
Net Debt / FCF Ratio	4.64	7.79	3.26	29.74	5.48	2.13
Asset Turnover	0.64	0.65	0.72	0.74	0.85	0.97
Inventory Turnover	3.96	4.07	4.45	4.35	4.94	5.76
Quick Ratio	0.69	0.75	0.66	0.80	0.80	0.80
Current Ratio	1.59	1.50	1.34	1.33	1.72	1.24
Return on Equity (ROE)	16.08%	17.47%	20.31%	21.69%	22.30%	27.53%
Return on Assets (ROA)	7.13%	7.65%	8.84%	8.81%	10.85%	10.71%
Return on Invested Capital (ROIC)	11.15%	13.10%	16.04%	16.00%	19.55%	21.34%
Return on Capital Employed (ROCE)	14.90%	16.20%	18.80%	19.40%	19.20%	23.10%
Earnings Yield	5.56%	4.61%	3.24%	3.19%	-	-
FCF Yield	2.30%	1.12%	1.73%	0.13%	-	-
Dividend Yield	1.06%	0.86%	0.53%	0.48%	-	-
Payout Ratio	18.98%	16.45%	15.09%	12.43%	9.14%	39.53%
Buyback Yield / Dilution	0.40%	-	-	-	0.00%	-
Total Shareholder Return	1.46%	0.86%	0.53%	0.48%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.